On the imbalanced protective arm of RAS in COVID-19: Lesson from rare genetic tubulopathies

Int J Clin Pract. 2021 May;75(5):e14075. doi: 10.1111/ijcp.14075.

Authors

Paul A Davis¹, Giovanni Bertoldi², Lorenzo A Calò²

Affiliations

¹ Department of Nutrition, University of California, Davis, CA, USA.
² Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Italy.

No abstract available

Publication types

Letter

MeSH terms

Angiotensin Receptor Antagonists
COVID-19*
Humans
Renin-Angiotensin System
SARS-CoV-2

Substances

Angiotensin Receptor Antagonists